Kodiak Sciences KOD Stock
Kodiak Sciences Price Chart
Kodiak Sciences KOD Financial and Trading Overview
| Kodiak Sciences stock price | 32.99 USD |
| Previous Close | 32.89 USD |
| Open | 33.21 USD |
| Bid | 30.95 USD x 200 |
| Ask | 55.16 USD x 200 |
| Day's Range | 32.96 - 33.89 USD |
| 52 Week Range | 9.1 - 47.84 USD |
| Volume | 55.12K USD |
| Avg. Volume | 675.52K USD |
| Market Cap | 2.11B USD |
| Beta (5Y Monthly) | 2.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.17 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 69.6 USD |
KOD Valuation Measures
| Enterprise Value | 1.99B USD |
| Trailing P/E | N/A |
| Forward P/E | -8.952649 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 34.425053 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -8.615 |
Trading Information
Kodiak Sciences Stock Price History
| Beta (5Y Monthly) | 2.18 |
| 52-Week Change | 251.76% |
| S&P500 52-Week Change | 15.74% |
| 52 Week High | 47.84 USD |
| 52 Week Low | 9.1 USD |
| 50-Day Moving Average | 39.98 USD |
| 200-Day Moving Average | 33.41 USD |
KOD Share Statistics
| Avg. Volume (3 month) | 675.52K USD |
| Avg. Daily Volume (10-Days) | 631.9K USD |
| Shares Outstanding | 62.85M |
| Float | 39.56M |
| Short Ratio | 18.37 |
| % Held by Insiders | 5.16% |
| % Held by Institutions | 102.42% |
| Shares Short | 10.78M |
| Short % of Float | 27.15% |
| Short % of Shares Outstanding | 17.15% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -60.44% |
| Return on Equity (ttm) | -368.37% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -230978000 USD |
| Net Income Avi to Common (ttm) | -241994000 USD |
| Diluted EPS (ttm) | -4.19 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 125.9M USD |
| Total Cash Per Share (mrq) | 2.01 USD |
| Total Debt (mrq) | 52.76M USD |
| Total Debt/Equity (mrq) | 86.35 USD |
| Current Ratio (mrq) | 2.489 |
| Book Value Per Share (mrq) | 0.974 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -158504992 USD |
| Levered Free Cash Flow (ttm) | -58392248 USD |
Profile of Kodiak Sciences
| Country | United States |
| State | CA |
| City | Palo Alto |
| Address | 1250 Page Mill Road |
| ZIP | 94304 |
| Phone | 650 281 0850 |
| Website | https://kodiak.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 141 |
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, engages in the research, development, and commercialization of therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor (VEGF) antibody biopolymer that has complete Phase 3 clinical study to treat high prevalence retinal vascular diseases; and in Phase 3 clinical study for the treatment of diabetic retinopathy, wet age-related macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema, as well as in Phase 2/3 clinical study to treat wet AMD. The company's preclinical stage product candidate includes KSI-501, an anti- interleukin-6 (IL-6) and VEGF-trap bispecific antibody biopolymer conjugate for high prevalence retinal vascular diseases; and KSI-101 (KSI-501P), a bispecific protein targeting IL-6 and VEGF developed for patients who have retinal fluid and inflammation. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.
Q&A For Kodiak Sciences Stock
What is a current KOD stock price?
Kodiak Sciences KOD stock price today per share is 32.99 USD.
How to purchase Kodiak Sciences stock?
You can buy KOD shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Kodiak Sciences?
The stock symbol or ticker of Kodiak Sciences is KOD.
Which industry does the Kodiak Sciences company belong to?
The Kodiak Sciences industry is Biotechnology.
How many shares does Kodiak Sciences have in circulation?
The max supply of Kodiak Sciences shares is 62.85M.
What is Kodiak Sciences Price to Earnings Ratio (PE Ratio)?
Kodiak Sciences PE Ratio is now.
What was Kodiak Sciences earnings per share over the trailing 12 months (TTM)?
Kodiak Sciences EPS is -4.17 USD over the trailing 12 months.
Which sector does the Kodiak Sciences company belong to?
The Kodiak Sciences sector is Healthcare.
Kodiak Sciences KOD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25981.57 USD — |
-0.78
|
7.07B USD — | 25943.31 USD — | 26172.12 USD — | — - | 7.07B USD — |
|
US Tech Global Market Composite
NQGM
US
|
2179.37 USD — |
-1.51
|
— — | 2176.53 USD — | 2211.26 USD — | — - | — — |
|
US Tech Biotechnology
NBI
US
|
6887.9 USD — |
-1.46
|
— — | 6841.27 USD — | 6974.62 USD — | — - | — — |
|
US Tech Health Care
IXHC
US
|
1294.5 USD — |
-1.07
|
— — | 1285.37 USD — | 1305.11 USD — | — - | — — |
|
Stlmt ID US Tech Biotechnology
NBX
US
|
4000.62 USD — |
-1.26
|
— — | 3927.42 USD — | 4148.65 USD — | — - | — — |
- {{ link.label }} {{link}}
